Commercial-Scale Gene Editing CDMOs
Gene Editing manufacturers on CDMO Signal: 5 listed, 5 with a Signal Score. Together they have 12 FDA inspections on file (including 7 NAI, 5 VAI and 0 OAI) and 13 EMA/MHRA GMP certificates. Fewer than three are fully evidenced (all four score pillars and at least one ClinicalTrials.gov match), so this page does not name a top three. The score does not measure which steps are done in-house (guide RNA, nuclease, delivery, or edited cells). Signal Score is computed from FDA inspection records, EMA EudraGMDP and MHRA GMP certificates, and ClinicalTrials.gov. CDMOs cannot pay to change it. Updated 2026-07-11. Methodology. This page is the commercial-scale filter: a high Signal Score or a broad ClinicalTrials.gov footprint. It is not a list of approved commercial products.
Gene editing CDMOs support CRISPR, base, and prime editing programs — spanning guide RNA and nuclease (mRNA or protein) supply, delivery (LNP, AAV, or electroporation), and, for ex vivo programs, edited-cell manufacturing.
Because a gene-editing program touches several modalities at once, CDMO selection often hinges on which steps a partner covers in-house versus coordinates. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 7 NAI (no action), 5 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (10), France (4), Germany (3), Ireland (3), UNITED KINGDOM (3).
Last updated 2026-07-11. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Ranked by Signal Score (0–100). Fully evidenced marks a CDMO scored on all four pillars with at least one confirmed clinical program. Partly scored and profile-only CDMOs follow the scored rows. How we score
Showing all operator types.
| # | CDMO | Signal Score | Quality | FDA · GMP | Last FDA inspection | Capacity | Programs |
|---|---|---|---|---|---|---|---|
| 1 |
CR
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
|
86.3 | 99.2 | 9 insp · 11 GMP | 2026-05-01 · NAI | Limited | — |
| 2 |
RC
|
79.3 | 96.8 | 1 insp · 1 GMP | 2025-01-21 · VAI | Available | — |
| 3 |
GP
San Diego, CA
|
78.1 | 100.0 | 0 insp · 1 GMP | None on file | — | — |
| 4 |
CS
Los Angeles, CA
Hiring · 1 open role
Fully evidenced
Academic / national centre
|
77.3 | 92.9 | 2 insp · 0 GMP | 2025-03-14 · NAI | — | 34 programs |
| 5 |
BY
|
75.2 | — | — | None on file | — | 126 programs |